atl101,177Lu-PSMA-617
telix,bzl biologics,novartis
['68g', 'crpc', 'prostact', 'prostate', 'telix', 'telix pharma']
yesterday telix presented #prostact select at #asco22, a study comparing #68ga- and #177lu-psma biodistribution and tumour uptake in men with psma-expressing metastatic castrate-resistant #prostatecancer (#mcrpc) progressing despite prior treatment with a novel androgen axis drug 
Telix is a "theranostics" company developing a pipeline of late-stage oncology assets in prostate cancer, renal cancer and glioblastoma. #SeeItTreatIt